Remineralization Effect Of Egg Shell Versus Fluoride Varnish On Early Carious White Spot Lesions In Primary Teeth
Remineralization Potential Of Egg Shell Hydrogel Versus Fluoride Varnish On Early Carious White Spot Lesions In Anterior Primary Teeth: A Randomized Controlled Trial
1 other identifier
interventional
66
0 countries
N/A
Brief Summary
The goal of this clinical trial is to to assess the remineralization potential of Egg shell hydrogel versus fluoride varnish in early carious white spot lesions in anterior primary teeth. The main question it aims to answer is:What is the remineralization potential of egg shell hydrogel on early carious white spot lesions compared to fluoride varnish in anterior primary teeth? Researcher will compare egg shell hydrogel with fluoride varnish to see if it is able to promote lesion remineralization. interventions that will be given to participasnts: egg shell hydrogel \& five percent sodium fluoride varnish
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_2
Started Sep 2025
Shorter than P25 for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2025
CompletedFirst Posted
Study publicly available on registry
April 17, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedMay 15, 2025
May 1, 2025
6 months
April 10, 2025
May 13, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Remineralization potential.
change in minerals content of the lesion , will be assessed using diagnodent scores ( minimum value is 0 and maximum value is 99 ) higher scores means worse outcome .
at 6th , 18 and 30th week
Secondary Outcomes (2)
Activity of the lesion
will be assessed using Nyvad's criteria at 6th , 18 and 30th week
Oral hygiene
at 6th , 18 and 30th week
Study Arms (2)
Egg shell hydrogel.
EXPERIMENTALFluoride varnish.
ACTIVE COMPARATORfive percent sodium fluoride varnish (Charm varnish -Dentkist- Korea).
Interventions
I. Nano-eggshell powder preparation: After cleaning, A small crack will be made in each eggshell to split it into two halves to evacuate the content. The eggshells will be disinfected in a hot water at 100°C for 10 minutes to facilitate the detachment of the inner membrane. They will be exposed to steam sterilization. Then they will be crushed using a sterile mortar and pestle. The crushed particles will be milled using a zirconia ball-milling machine at 200 rpm . This will result in a nano-sized eggshell powder to incorporate them into a gel form. II. Preparation of eggshell hydrogel formulations: through dispersing a suitable concentration of egg shell powder in distilled water, followed by dissolving the gelling agent; sodium carboxymethyl cellulose at a concentration of 5-10% under continuous stirring. The formed hydrogel will be kept at 8°C for a period of 24 hours before further use. This will produce a paste of consistency that is appropriate for handling and application.
five percent sodium fluoride varnish (Charm varnish -Dentkist- Korea).
Eligibility Criteria
You may qualify if:
- Children aged 3 to 5 years, in good general health, and medically free.
- Prescence of at least one WSL on anterior primary teeth with an ICDAS II score of one or two.
- Cooperative patients who will comply with follow-ups.
- Parents who accept to sign informed consent.
You may not qualify if:
- Uncooperative children.
- Children with a physical disability or medical disability.
- Children with teeth that shows enamel hypoplasia.
- Children that have received a fluoride supplement or professional topical fluoride application at least 3 months before the study.
- Parents refuse to give written formed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 10, 2025
First Posted
April 17, 2025
Study Start
September 1, 2025
Primary Completion
March 1, 2026
Study Completion
March 1, 2026
Last Updated
May 15, 2025
Record last verified: 2025-05